Caroline Nievergelt
Has grant
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Open
Next steps for PTSD genomics: from loci to function
Open Date: 2024-05-17
Close Date: 2029-03-31
Grant: Open
Genetics of PTSD in African Ancestry Populations
Open Date: 2023-08-25
Close Date: 2028-07-31
Grant: Close
Genetic Architecture of Tinnitus and its Relationship to Hearing Loss
Open Date: 2022-07-01
Close Date: 2026-06-30
Grant: Close
4/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact
Open Date: 2021-04-10
Close Date: 2026-02-28
Grant: Open
Genomic Architecture of Functional Brain Networks in PTSD
Open Date: 2017-09-06
Close Date: 2026-12-31
Articles (6)
Chronic prostatitis/chronic pelvic pain syndrome is common, and it impacts men’s health and quality of life. The genetic basis of this condition remains largely unknown. Here, we conduct a GWAS using data from the Million Veteran Program of over 590,000 men of European, African, and Hispanic ancestry, including 14,575 chronic prostatitis/chronic pelvic pain syndrome cases. The multi-ancestry analysis identifies eight novel loci associated with chronic prostatitis/chronic pelvic pain syndrome risk, an increase from three significant genome-wide loci found in the European participants alone. We also estimate the genetic correlations between chronic prostatitis/chronic pelvic pain syndrome and 12 phenotypes. Notably, the genetic correlation between chronic prostatitis/chronic pelvic pain syndrome and prostate cancer is not significant. Further, Mendelian randomization shows a significant, potentially bidirectional causal relationship between chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia, but not between chronic prostatitis/chronic pelvic pain syndrome and prostate cancer, suggesting a complex interplay between chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia. Results of bivariate causal mixture modeling indicate that some of the same genetic variants likely contribute to the development of chronic prostatitis/chronic pelvic pain syndrome, benign prostatic hyperplasia, and prostate cancer.
Year:
2026
Migraine is a neurovascular disorder that poses a high burden to Veterans, who face a greater risk than sex-matched individuals in the general population. Genetic research on migraine in Veterans and its link to psychiatric comorbidities is limited. We present a meta-analysis of a genome-wide association study (GWAS) of migraine in a predominantly male sample of over 433,000 Veterans, including 87,859 cases, from the Million Veteran Program (MVP), identifying 49 genome-wide significant loci, with 36 novel to this study, of which 7 replicated in an independent prior GWAS (after Bonferroni correction for number of loci tested). Our analyses revealed 283 genes, including some newly associated with migraine: MAML3, CELF4, IRX1, ASXL1, SPOCD1, CXCL , and TLR4 . In silico analyses showed enrichment in brain and uterine tissues, which may reflect broader hormonal or neuroendocrine pathways. Compared to previous migraine GWAS, our results show minimal vascular tissue enrichment, potentially reflecting the sample composition, which was predominantly men and Veterans. Migraine SNP-based heritability was 10% for men and 16% for women, and several sex-specific loci were identified through sex-stratified analyses. Despite high genetic correlations with neuropsychiatric disorders – including post-traumatic stress disorder, depression, and traumatic brain injury – Mendelian randomization analyses found no causal links. Finally, we prioritized potential migraine drug targets, including losmapimod (which reduces production of toxic DUX4 protein) and TLR4 antagonists.
Year:
2025
Background Disabling age-related and noise-induced sensorineural hearing loss (SNHL) affects 5% of the global population and is associated with isolation, depression, cognitive decline, and dementia. SNHL is strongly heritable with a polygenic signature of common genetic variants conferring small risks individually, thus requiring very large studies to achieve statistical power in genome-wide association studies (GWAS). Methods We present the first report of a clinical SNHL GWAS in the Million Veteran Program (MVP) cohort. GWAS findings are examined separately within MVP (210,240 cases and 265,275 controls), including multi-ancestry analysis, then combined and contrasted with the United Kingdom Biobank (UKB) self-reported hearing loss study (87,056 cases and 163,333 controls). We perform functional mapping and annotation, gene prioritization, gene-based and gene-set analysis, and cochlear cell type enrichment, including human single-cell results, then compare our results to known hereditary hearing loss genes. Summary results are leveraged to characterize the genetic architecture of SNHL. Results Substantial genetic overlap is seen between MVP and UKB despite differences in phenotypes, demographics, and environmental exposures. Individual GWAS and meta-analyses identify 108 loci, including 54 loci containing novel prioritized genes and/or protein-coding genes. Significant gene ontology pathways include “sensory perception of mechanical stimulus,” “ear development,” “actin-binding,” and “cytoskeletal protein binding,” indicative of mechanosensory structure and function in the cochlea. GWAS and gene-based analyses implicate 17 known familial hearing loss genes, expressing proteins in regions of hair cells, Type 1 neurons, stria vascularis, and subcellular regions of stereociliae, rootlets, and notably, mechanoelectrical transduction tip-links. Although risk for polygenic SNHL is predominantly captured by SNPs outside of congenital HHL genes (HHL), SNP-based partitioned heritability estimates show a 3.26-fold enrichment of HHL relative to other genes. Conclusion In the largest GWAS to date, combining clinical diagnosis of hearing loss and self-report data from two cohorts, we identify 108 loci with 54 novel genes. Despite the increased enrichment of HHL genes, 97% of the risk for adult SNHL is captured by SNPs outside of HHL genes. Although SNHL in the UKB and MVP were assessed using different phenotypes, genetic signals between the two cohorts are predominantly shared, and locus discovery is boosted through increased sample size in meta-analysis.
Year:
2025
Importance Biomarkers can potentially improve the diagnosis, monitoring, and treatment of posttraumatic stress disorder (PTSD). However, PTSD biomarkers that are scalable and easily integrated into real-world clinical settings have not been identified. Objective To triangulate phenotypic and genomic evidence from a health system biobank with a goal of identifying scalable and clinically relevant biomarkers for PTSD. Design, setting, and participants The analysis was conducted between June to November 2024 using genomic samples and laboratory test results recorded in the Mass General Brigham (MGB) Health System. The analysis included 23,743 European ancestry participants from the nested MGB Biobank study. Exposures The first exposure was polygenic risk score (PRS) for PTSD, calculated using the largest available European ancestry genome-wide association study (GWAS), employing a Bayesian polygenic scoring method. The second exposure was a clinical diagnosis of PTSD, determined by the presence of two or more qualifying PTSD phecodes in the longitudinal electronic health records (EHR). Main outcomes and measures The primary outcomes were the inverse normal quantile transformed, median lab values of 241 laboratory traits with non-zero h 2 SNP estimates. Results Sixteen unique laboratory traits across the cardiometabolic, hematologic, hepatic, and immune systems were implicated in both genomic and phenotypic lab-wide association scans (LabWAS). Two-sample Mendelian randomization analyses provided evidence of potential unidirectional causal effects of PTSD liability on five laboratory traits. Conclusion and relevance These findings demonstrate the potential of a triangulation approach to uncover scalable and clinically relevant biomarkers for PTSD. Key points Question Is genetic liability or diagnosis of PTSD associated with clinical laboratory measures? Findings Among European ancestry participants in the MGB Biobank, we identified 16 unique laboratory traits in cardiometabolic, hematologic, hepatic, and immune systems that were both genetically and phenotypically associated with PTSD, with five markers demonstrating potential unidirectional causal effects of PTSD liability. Meaning Our findings reveal associations between PTSD and laboratory markers across multiple physiological systems, with evidence suggesting possible unidirectional causal effects of PTSD liability on cardiometabolic, hematologic, and hepatic markers.
Year:
2025
Psychiatric disorders display high levels of comorbidity and genetic overlap 1,2 . Genomic methods have shown that even for schizophrenia and bipolar disorder, two disorders long-thought to be etiologically distinct 3 , the majority of genetic signal is shared 4 . Furthermore, recent cross-disorder analyses have uncovered over a hundred pleiotropic loci shared across eight disorders 5 . However, the full scope of shared and disorder-specific genetic basis of psychopathology remains largely uncharted. Here, we address this gap by triangulating across a suite of cutting-edge statistical genetic and functional genomic analyses applied to 14 childhood- and adult-onset psychiatric disorders (1,056,201 cases). Our analyses identify and characterize five underlying genomic factors 6 that explain the majority of the genetic variance of the individual disorders (∼66% on average) and are associated with 268 pleiotropic loci. We observed particularly high levels of polygenic overlap 7 and local genetic correlation 8 and very few disorder-specific loci 9 for two factors defined by: ( i ) schizophrenia and bipolar disorder (“SB factor”), and by ( ii ) major depression, PTSD, and anxiety (“internalizing factor”). At the functional level, we applied multiple methods 10–12 which demonstrated that the shared genetic signal across the SB factor was substantially enriched in genes expressed in excitatory neurons, whereas the internalizing factor was associated with oligodendrocyte biology. By comparison, the genetic signal shared across all 14 disorders was enriched for broad biological processes (e.g., transcriptional regulation). These results indicate increasing differentiation of biological function at different levels of shared cross-disorder risk, from quite general vulnerability to more specific pathways associated with subsets of disorders. These observations may inform a more neurobiologically valid psychiatric nosology and implicate novel targets for therapeutic developments designed to treat commonly occurring comorbid presentations.
Year:
2025
In recent years, significant efforts have been made to improve methods for genomic studies of admixed populations using Local Ancestry Inference (LAI). Accurate LAI is crucial to ensure downstream analyses reflect the genetic ancestry of research participants accurately. Here, we test analytic strategies for LAI to provide guidelines for optimal accuracy, focusing on admixed populations reflective of Latin America’s primary continental ancestries – African (AFR), Amerindigenous (AMR), and European (EUR). Simulating LD-informed admixed haplotypes under a variety of 2 and 3-way admixture models, we implemented a standard LAI pipeline, testing three reference panel compositions to quantify their overall and ancestry-specific accuracy. We examined LAI miscall frequencies and true positive rates (TPR) across simulation models and continental ancestries. AMR tracts have notably reduced LAI accuracy as compared to EUR and AFR tracts in all comparisons, with TPR means for AMR ranging from 88-94%, EUR from 96-99% and AFR 98-99%. When LAI miscalls occurred, they most frequently erroneously called European ancestry in true Amerindigenous sites. Using a reference panel well-matched to the target population, even with a lower sample size, LAI produced true-positive estimates that were not statistically different from a high sample size but mismatched reference, while being more computationally efficient. While directly responsive to admixed Latin American cohort compositions, these trends are broadly useful for informing best practices for LAI across other admixed populations. Our findings reinforce the need for inclusion of more underrepresented populations in sequencing efforts to improve reference panels.
Year:
2024
Collaborators (40)
Jordan Smoller
Professor
Massachusetts General Hospital
Naomi Wray
University of Queensland
Stephen V Faraone
Distinguished Professor
SUNY Upstate Medical University
G. Bragi Walters
Research Assistant Professor
University of Iceland
Howard Edenberg
Distinguished Professor
Indiana University School of Medicine
Matthew Panizzon
Professor
University of Washington
Clement C Zai
Associate Professor
University of Toronto
Susan Santangelo
Research Professor
Tufts University School of Medicine
Ditte Demontis
Aarhus University
Na Cai
Assistant Professor
ETH Zürich
Tian Ge
Broad Institute
Andrea Roberts
Principal Research Scientist
Harvard T.H. Chan School of Public Health
James Knowles
Distinguished Professor and Executive Director of the HGINJ
Rutgers University - Busch Campus
Joanna Biernacka
Associate Professor
Mayo Clinic
Andrew Grotzinger
Associate Professor
Memorial University of Newfoundland
Benjamin Neale
Associate Professor
Broad Institute
Kenneth S. Kendler
Professor
Virginia Commonwealth University
John Hettema
Professor
Texas A&M University
Phil Lee
Associate Professor
Massachusetts General Hospital
Oleksandr Frei
Associate Professor (20%)
University of Oslo
Sandra Sanchez-Roige
Associate Professor
University of California, San Diego
Murray Stein
Distinguished Professor
University of California, San Diego
Laura Thornton
Research Professor
University of North Carolina
Kari Stefansson
Professor
University of Iceland
Elizabeth Atkinson
Assistant Professor
Baylor College of Medicine
Joel Gelernter
Professor
Yale University School of Medicine
Manuel Mattheisen
Associate Professor
Ludwig-Maximilians-Universität München
Barbara Franke
Head of department
Radboud University Medical Center
Michael Gandal
William & Noreen Hetznecker Associate Professor
University of Pennsylvania
Royce Clifford
Research Scientist
UC San Diego Health System
Justin D Tubbs
Assistant Professor
Massachusetts General Hospital
Josefin Werme
University of Amsterdam
Karen Mitchell
Assistant Professor
Boston University
Elliot M. Tucker-Drob
Faculty Research Associate
University of Texas at Austin
Ole A. Andreassen
Oslo University Hospital
Irwin Waldman
Professor
Emory University
Brandon Coombes
Assistant Professor of Biostatistics
Mayo Clinic
Wouter Peyrot
VU medisch centrum
Katherine Jonas
Assistant Professor
Stony Brook University
John Nurnberger
Professor/Distinguished Professor
Indiana University School of Medicine
Make your next move.
Prepare your application
Review drafts before you send them.